Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.

Layered wound closure trumps deep-dermal single-layer sutures in short-term

29 Nov 2019

Layered wound closure techniques have a slight advantage over single-layer techniques in terms of scar outcomes, according to a recent trial.

Researchers enrolled 49 patients (mean age, 65.5±10.4 years; 73.5 percent male) who underwent cutaneous wound closure through single-layer deep-dermal suturing and the conventional bilayered closure technique. The primary study outcome was the mean score in the Patient and Observer Scale Assessment Scale (POSAS) at 3 and 12 months.

After 3 months, the mean blind observer POSAS score was slightly but significantly higher in the dermal suture side of the wound than in the side treated with the layered closure technique (13.96 vs 11.80; p=0.02). Higher POSAS scores indicated worse scar quality.

Significant differences between the scar sides were observed in the POSAS subcategories of vascularity (p=0.02), thickness (p=0.01) and pliability (p=0.01), all favouring layered closure.

Mean patient POSAS feedback were similar, such that 3-months cores were significantly greater for the dermal suture-only side (16.53 vs 13.31; p=0.02). This was driven by the comparative advantage of the layered closure technique in the subcategories of colour (p=0.01), thickness (p=0.01) and irregularity (p=0.03).

However, in both the blind-observer and patient POSAS assessments, layered suturing could not maintain its superiority such that any statistical significance over its single-layer comparator was attenuated by the 12-month follow-up. The only exception was patient-noted scar colour, which remained better in the layered suture side (p=0.015).  

Editor's Recommendations
Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.